Eerais Miller
Family · Visalia, CANPI 1346908399
Payments from drug & device makers
Across 99 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$555
- Lilly USA, LLC$404
- AbbVie$350
- Amgen$250
- Boehringer Ingelheim$193
- LEO Pharma Inc.$118
- plus $629 from 15 others
What the payments were for
- Food & beverage$2,499100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $555 |
| Lilly USA, LLC | 13 | $404 |
| AbbVie | 21 | $350 |
| Amgen | 10 | $250 |
| Boehringer Ingelheim | 9 | $193 |
| LEO Pharma Inc. | 1 | $118 |
| Bayer | 5 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $75 |
| Novo Nordisk | 3 | $62 |
| GSK | 3 | $58 |
| Pfizer | 3 | $55 |
| Dexcom, Inc. | 2 | $52 |
| Sanofi | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Organon | 1 | $24 |
| Pulmonx Corporation | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Abbott | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Biocryst US Sales Co., LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,499 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 27 | $56,402 |
| FarxigaDapagliflozin Propanediol | 40 | $51,392 |
| EliquisApixaban | 37 | $33,880 |
| OzempicSemaglutide | 37 | $32,158 |
| MounjaroTirzepatide | 22 | $21,573 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $14,522 |
| TradjentaLinagliptin | 15 | $10,752 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $5,882 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $5,217 |
| Varenicline Tartrate | 12 | $2,314 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 48 | $1,713 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $1,677 |
| Atorvastatin Calcium | 197 | $1,486 |
| Fluconazole | 13 | $1,340 |
| Metoprolol Succinate | 63 | $1,259 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $62 | $88,56164 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $555 | $65,91464 claims |
| PfizerEliquis | $55 | $33,88037 claims |
| Lilly USA, LLCMounjaro | $404 | $21,57322 claims |
| Boehringer IngelheimTradjenta | $193 | $10,75215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.
Other family in Visalia
- Pamela ScottVisalia$165K
- Maribel TorresVisalia$57K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.